Association of Asymmetric Dimethylarginine and Nitric Oxide with Cardiovascular Risk in Patients with End-Stage Liver Disease.
Maro DragičevićIva KošutaEgon KrueziMarijana Vučić LovrenčićAnna MrzljakPublished in: Medicina (Kaunas, Lithuania) (2020)
These results suggest a remarkable contribution of the deranged arginine/NO pathway to cardiovascular risk in patients with end-stage liver disease.